Evidence map›Paper›PMID 42306573›Full record

ArticleResearch in pharmaceutical sciences2026

Abbas Alibakhshi, Shima Gharibi, Ali Shojaeian, Atefeh Asgari, Razieh Amini, Mehdi Rahimmalek, Shahrzad Ahangarzadeh, Antoni Szumny

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Research in pharmaceutical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abbas AlibakhshiResearch Center for Molecular Medicine, Institute of Cancer, Avicenna Health Research Institute (AHRI), Hamadan University of Medical Sciences, Hamadan, I.R. Iran.
Shima GharibiPharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan 81746-73461, I.R. Iran.
Ali ShojaeianResearch Center for Molecular Medicine, Institute of Cancer, Avicenna Health Research Institute (AHRI), Hamadan University of Medical Sciences, Hamadan, I.R. Iran.
Atefeh AsgariStudent Research Committee, Hamadan University of Medical Sciences, Hamadan 65178-38678, I.R. Iran.
Razieh AminiResearch Center for Molecular Medicine, Institute of Cancer, Avicenna Health Research Institute (AHRI), Hamadan University of Medical Sciences, Hamadan, I.R. Iran.
Mehdi RahimmalekDepartment of Horticulture, College of Agriculture, Isfahan University of Technology, Isfahan 84156-83111, I.R. Iran.
Shahrzad AhangarzadehRegenerative Medicine Research Center, Isfahan University of Medical Sciences, Isfahan 81746-73461, I.R. Iran.
Antoni SzumnyDepartment of Food Chemistry and Biocatalysis, Wroclaw University of Life Sciences, 50-375 Wroclaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Colorectal cancer (CRC) is a significant global health challenge, necessitating a comprehensive molecular understanding for personalized treatments. Molecular profiling has elucidated key biomarkers that are essential for prognosis, treatment responsiveness, and targeted therapeutic interventions. Experimental approach: This study explored the role of indigenous phytochemicals, using bioinformatics and experimental assays to identify potential CRC-specific therapeutic targets. Findings/Results: A system biology and drug-target network analysis identified four proteins (ANG, DPP4, INSR, and MAPK14) as potential targets for further investigation. Molecular docking studies showed that the cauferoside from Conclusion and implications: The findings suggest the potential therapeutic efficacy of

Indexed as

Colorectal cancerFerula gummosaMolecular dockingMolecular dynamicsPhytochemicalsSystem biology.

Identifiers

PMID42306573
PMCPMC13268007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.